Vanguard Group Inc Aditxt, Inc. Transaction History

Vanguard Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.14 - $135.6 $176,182 - $171 Million	-1,258,447 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.54 - $2.51 $568,944 - $2.64 Million	1,053,600 Added 514.34%	1,258,447 $674,000
Q3 2021 Nov 12, 2021	BUY	$1.54 - $3.04 $11,941 - $23,572	7,754 Added 3.93%	204,847 $346,000
Q2 2021 Aug 13, 2021	BUY	$2.2 - $3.2 $433,604 - $630,697	197,093 New	197,093 $510,000

Ticker ADTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,161,130
Market Cap $1.41M
Description
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immuno...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.